Skip to main content
Equibles

Verition Fund Management LLC

Position in TECH — BIO-TECHNE Corp

CIK 1454027 GREENWICH, CT
Back to TECH Full portfolio

Position in TECH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,997,404
+$28,200,502 QoQ
Shares Held
438,746
+719.8% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TECH Over Time

Shares Held

Position Value (USD)

Derivatives in TECH

reported options exposure · as of Jun 30, 2026
CallValue
$51,002,235
CallShares
721,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $156,064,619 across 64 Biotechnology names. TECH ranks #1 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
This page 		438,746 $30,997,404
2
159,256 $21,138,048
3 ABVX
Abivax S.A.
 105,791 $14,097,708
4 IDYA
IDEAYA Biosciences, Inc.
 184,054 $6,859,692
5 SNDX
Syndax Pharmaceuticals Inc
 304,939 $6,665,966
6 MRVI
Maravai Lifesciences Holdings, Inc.
 777,738 $4,853,085
7 CYTK
Cytokinetics Inc
 54,889 $4,675,993
8 RPRX
Royalty Pharma plc
 75,000 $4,205,250

All Filings in TECH

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,002,235 721,900
2026-06-30 $30,997,404 438,746
2026-03-31 $2,796,902 53,519
2025-12-31 $5,589,420 95,042
2025-09-30 $3,035,117 54,559
2025-06-30 $2,213,996 43,032
2025-03-31 $1,723,839 29,402
2024-12-31 $689,831 9,577
2024-09-30 $736,315 9,212
2024-06-30 $685,690 9,570
2024-03-31 $695,875 9,886
2023-12-31 $756,862 9,809
2023-09-30 $1,145,618 16,830
2023-06-30 $801,116 9,814
2023-03-31 $830,779 11,198
2022-12-31 $315,607 3,808
2022-09-30 $287,976 1,014
2021-06-30 $519,600 1,154